Received Sep 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | Z53J4 | IM / LA |
patient was given expired infanrix; This non-serious case was reported by a nurse via sales rep and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa (Infanrix) (batch number Z53J4, expiry date 07-JUN-2025) for prophylaxis. On 07-AUG-2025, the patient received the 1st dose of Infanrix (intramuscular, left deltoid). On 07-AUG-2025, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: patient was given expired infanrix). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-Aug-2025 Provider of the record realized Infanrix was expired after administration to patient. No adverse event had been reported to date.